Organon & Co | DEBITO



Debt Cambiamento Data
Adcock Ingram Holdings ZAR 969.4M 688.86M 2024-12
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Celltrion KRW 2.22T 24.87B 2025-03
Cspc Pharmaceutical CNY 507.33M 118.46M 2024-12
Dianthus Therapeutics USD 1.33M 161K 2025-06
Divis Laboratories Ltd 40M 40M 2025-03
Gilead Sciences USD 24.95B 6M 2025-06
Glaxosmithkline GBP 17.35B 368M 2025-06
Kangmei Pharma CNY 221.82M 958.68M 2025-03
Knight Therapeutics CAD 58.22M 109K 2024-09
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 2.14M 144K 2024-12
Merck USD 34.84B 2.27B 2025-03
Neuren Pharmaceuticals AUD 0 0 2024-12
Novartis USD 32.64B 1.38B 2025-06
Organigram Holdings CAD 9.15M 35.6M 2025-06
Organon & Co USD 8.9B 60M 2025-06
Pharma Mar EUR 51.4M 405K 2025-06
Qiagen NV USD 1.44B 35.7M 2025-06
Sartorius EUR 4.66B 25.7M 2025-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Tilray USD 351.72M 15.26M 2024-11


Organon & Co DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.